XML 51 R41.htm IDEA: XBRL DOCUMENT v3.25.0.1
STOCK-BASED COMPENSATION (Tables)
 9 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Options
The following table summarizes the activity relating to the Company’s market-based stock options for the nine-month period ended December 31, 2024:
OptionsWeighted-
Average
Exercise Price 		Weighted Average Contractual Remaining Term (years)
Aggregate Intrinsic Values (in thousands)
Outstanding as of April 1, 2024
5,445 13.39 — — 
Granted— — — — 
Exercised— — — — 
Forfeited(50)3.13 — — 
Outstanding as of December 31, 2024
5,395 13.487.21$4,414 
Vested as of December 31, 2024
— — — $— 
The following table summarizes the activity relating to the Company’s stock options, excluding the market-based stock options, for the nine-month period ended December 31, 2024:

OptionsWeighted-
Average
Exercise Price		Weighted Average Contractual Remaining Term (years)
Aggregate Intrinsic Values (in thousands)
Outstanding as of April 1, 2024
1,979 4.68 — — 
Granted375 4.31 — — 
Exercised(161)5.45 — — 
Forfeited(86)5.14 — — 
Outstanding as of December 31, 2024
2,107 4.546.84$4,496 
Vested as of December 31, 2024
1,807 4.58 6.41$3,791 
Schedule of Fair Value Valuation Assumptions
The fair value of each option grant on the date of grant is estimated using the Black-Scholes option-pricing model reflecting the following weighted-average assumptions:

December 31, 2023December 31, 2024
Expected volatility 55.6 %60.2 %
Expected life of options6.16.5
Risk free interest rate3.87 %4.23 %
Dividend yield— — 
Weighted-average fair value of options granted during the year$1.66$2.66
Schedule of Restricted Stock Activity A summary of all unvested restricted stock for the nine-month period ended December 31, 2024 is as follows:
Number of
Unvested Shares
Weighted- Average
Grant Date Fair Value
Unvested, March 31, 2024
1,370 2.68 
Granted54 5.45 
Vested/Exercised
(1,370)2.68 
Forfeited or expired— — 
Unvested, December 31, 2024
54 5.45 
Schedule of Unvested SARs Activities
The following table summarizes the activities for the outstanding SARs:

Number of SARsWeighted-
Average
Exercise Price		Weighted Average Contractual Remaining Term (years)
Aggregate Intrinsic Values (in thousands)
Outstanding as of April 1, 2024
— — 
Acquired through MiX Combination5,740 2.61 
Granted— — 
Exercised(1,343)2.96 
Forfeited(498)2.43 
Outstanding as of December 31, 2024
3,899 2.513.10
Vested as of December 31, 2024
1,293 2.92 1.80$4,847